drugset / Trial / NCT02858271
Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778
NaSingle-groupOpen-labelTreatment
Summary
Open-label, single-dose, Phase 1 study to assess the absorption, metabolism, excretion and pharmacokinetics of \[14C\]-AKB-9778 in healthy male volunteers
Timeline
- Start
- 2016-07
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AKB-9778 | Unknown | — | Subcutaneous |
Indications
No indication recorded.